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ABSTRACT: We describe the first example of a mitochondrial protein with a covalently attached phos- 
phatidylinositol moiety acting as a membrane anchor. The protein can be metabolically labeled with both 
stearic acid and inositol. The stearic acid label is removed by phospholipase D whereupon the protein with 
the retained inositol label is released from the membrane. This protein is a cAMP receptor of the yeast 
Saccharomyces cereuisiae and tightly associated with the inner mitochondrial membrane. However, it is 
converted into a soluble form during incubation of isolated mitochondria with Ca2+ and phospholipid (or 
lipid derivatives). This transition requires the action of a proteinaceous, N-ethylmaleimide-sensitive component 
of the intermembrane space and is accompanied by a decrease in the lipophilicity of the cAMP receptor. 
We propose that the component of the intermembrane space triggers the amphitropic behavior of the 
mitochondrial lipid-modified CAMP-binding protein through a phospholipase activity. 
Only in recent years specific fatty acids have been recog- 
nized to play important roles in the association of proteins with 
membranes. Both noncovalent and covalent interactions be- 
tween fatty acids and proteins have been reported. Among 
the latter are GTP-binding proteins (Molenaar et al., 1988), 
ras proteins (Fujiama & Tamanoi, 1986; Deschenes & Broach, 
1987), tyrosine kinases like p6OSrc (Buss et al., 1984), cell 
surface receptors like IGF receptor I1 and cation-independent 
mannose 6-phosphate receptor (Morgan et al., 1987; Westcott 
& Rome, 1988), murine T-cell-specific surface antigen Thy1 
(Tse et al., 1985), trypanosomal coat protein VSG (Schmitz 
et ai., 1987), mammalian plasma membrane enzymes like 
alkaline phosphatase and 5”Icleotidase (Jemmerson & Low, 
1987), human carcinoembryonic antigen (Takami et al., 
1988a), and the decay accelerating factor of complement 
(Medof et al., 1986). 
Fatty acids may be. attached directly via oxyester or thioester 
bonds (Willumsen et al., 1984; Chen et al., 1985), the latter 
often being the case for ras and ras-related proteins in yeast 
as well as in mammals (Buss & Sefton, 1986) and several 
GTP-binding proteins in mammals [for review, see Barbacid 
(1987)l. Kinetic analyses showed that the palmitylated po- 
lypeptides ankyrin and anion transporter are continuously 
acylated and deacylated at the erythrocyte plasma membrane 
(Staufenbiel, 1988). The deacylation reaction was not simply 
due to a chemical instability of the acyl groups but appeared 
to be physiologically induced, suggesting that reversible 
palmitylation of proteins may serve to modulate the protein’s 
function and intracellular location. 
The fatty acid may also be bound indirectly via a complete 
lipid side chain covalently attached to the protein. Most 
commonly found is phosphatidylinositol glycan (Cross, 1987; 
Low, 1987), which anchors proteins to the extracellular face 
of the plasma membrane. This structure is added post- 
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translationally to many plasma membrane proteins in mam- 
mals [e.g., alkaline phosphatase (Ogata et al., 1988)], Tryp- 
anosoma brucei [variant surface glycoproteins (Ferguson et 
a]., 1985; Menon et al., 1988)], Dictyostelium discoideum 
[contact site A glycoprotein (Stadler et al., 1989)], and yeast 
(Conzelmann et al., 1988). However, in all cases where lipids 
are responsible for membrane anchoring of proteins, it is un- 
clear whether their attachment is regulated and thereby 
controls a dual location of the protein or whether the lipid 
modification exclusively represents a step in the biosynthesis 
of this type of membrane protein for a unique location (Bangs 
et al., 1985). Removal of a lipid membrane anchor has not 
been observed in vivo, but in the case of the membrane-as- 
sociated cytoskeletal protein a-actinin (Burn, 1988) and of 
some eucaryotic plasma membrane proteins [alkaline phos- 
phatase (Low & Prasad, 1988); trypanosomal VSG (Cardoso 
de Almeida & Turner, 1983; Bulow & Overath, 1986)], it has 
been speculated that both covalent modification by a lipid and 
its removal by lipase action may be involved in the association 
with and dissociation from the plasma membrane, respectively. 
Up to now, covalent lipid modification seemed to be re- 
stricted to plasma membrane proteins (Low & Saltiel, 1988) 
whereas acylation of proteins with long-chain fatty acids was 
also reported for some membrane-associated proteins of the 
Golgi complex (Segev et al., 1988) and of secretory vesicles 
(Goud et al., 1988). Mitochondria have so far not been ob- 
served to harbor proteins embedded into their membranes via 
a fatty acid or a complete lipid moiety. 
In  an accompanying paper we demonstrate that a 
CAMPI-binding protein in mitochondria of the yeast Sac- 
charomyces cereuisiae is amphitropic and occurs in a mem- 
brane-bound as well as in a soluble version (Muller & 
Bandlow, 1989a). Surprisingly, both forms exhibit the same 
apparent molecular weight, indicating that release from the 
membrane is not effected by proteolysis. Here we present 
evidence that this protein is anchored in the inner membrane 
via a covalently linked inositol-containing phospholipid, in- 
’ Abbreviations: see accompanying paper (Muller & Bandlow, 
1989a). 
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Lipid-Anchored CAMP-Binding Protein 
troducing a new type of protein attachment to mitochondrial 
membrane. In addition, a protein of the intermembrane space 
and a phospholipase activity were found to be responsible for 
the Ca2+- and phospholipid-controlled release of the cAMP 
receptor into the intermembrane space. 
MATERIALS AND METHODS 
Materials. Phospholipases A2 (bee venom), C (Bacillus 
cereus). and D (cabbage), esterase (pig liver), and RNase A 
were purchased from Boehringer, Mannheim; urographin was 
bought from Schering AG, Berlin; [I-I4C]stearic acid 60 
mCi/mmol), my0-[2-~H]inositol ( I  5 Ci/mmol), and N- 
[3H]acetylconcanavalin A (45 Ci/mmol) were provided by 
Amersham-Buchler, Braunschweig; N-ethylmaleimide and 
hydroxylamine were from Sigma, Taufkirchen; all other 
chemicals were obtained as described (Miiller & Bandlow, 
1989a). 
Yeast Strains, Growth Conditions, and Preparation of 
Mitochondria. Mitochondria were prepared from the pro- 
tease-deficient yeast strain ABYS-66 (haploid), grown at 30 
OC in lactate medium (Daum et al., 1982) and subsequently 
purified by equilibrium density centrifugation on 28% Percoll 
gradient (Miiller & Bandlow, 1989a). 
Metabolic Labeling of the CAMP-Binding Protein. Yeast 
strain PEP4-3 was grown overnight at 30 OC in semisynthetic 
SD medium (Wickerham, 1946) containing 50 mM (NH)$O, 
as N source, 2% glucose as C source, and IO p M  myo-inositol 
and harvested (OD, = 1.0). The pellet was resuspended in 
IO volumes of SD medium with 2.5% lactate instead ofgluccse. 
After growth for 6 h at 30 OC (OD, = 0.4). cells were 
wllected by centrifugation. For labeling with fatty acids, cells 
corresponding to 10-15 ODsm were incubated in 2 mL of S D  
medium in the presence of 1 mCi of [lJ4C]stearic acid (2 h, 
30 “C) (stearic acid in toluene was added to glass tubes and 
dried under N2, SD medium was added, and the fatty acid was 
suspended by mild sonication for 15 min before addition of 
cells). For labeling with myo-inositol, cells were incubated 
in 2 mL of myo-inositol-free S D  medium with 0.5 mCi of 
myo-[2-’H]inositol. The labeling reactions were terminated 
by the addition of a 100-fold molar excess of unlabeled stearic 
acid or inositol, respectively, and by placing the tubes on ice. 
Mitochondria were prepared, incubated with or without Ca*+ 
and TPA, supplemented with EGTA (final wncentration 100 
pM), spun through a cushion of 0.4 M sucme (IO min, 4 OC, 
20000 rpm, Beckman TL-100, swing-out rotor), resuspended 
(2 mg/mL in binding buffer plus 0.5% MEGA IO), homo- 
genized by ten strokes in a tightly fitting Dounce homogenizer, 
and centrifuged (IO min, 4 OC, 250000g). The supernatant 
was applied to a CAMP-Sepharose column (Muller & 
Bandlow, 1989b). After being washed with binding buffer, 
the protein was eluted with 0.1 M cAMP and concentrated 
by precipitation with 30% PEG 4000. 
Subfactionation ofmitochondria, the CAMP-binding assay, 
photoaffinity labeling, and polyacvlamide gel electrophoresis 
were carried out as described (Miiller & Bandlow, 1987a.b. 
1989a). The Ca” phospholipid-controlled releasing reaction 
was routinely carried out in the presence of 50 p M  Ca” and 
0.5 pg/mL TPA for IO min a t  25 OC. 
RESULTS 
Calcium/Phospholipid-Controlled Release of the CAMP- 
Binding Protein Is Mimicked by Treatment of Mitoplasts with 
Phospholipase. The p d i n g  paper describes a mitochondrial 
CAMP-binding protein which normally behaves as an integral 
membrane protein but can be released into the soluble in- 
termembrane space upon treatment of isolated mitochondria 
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FIGURE I :  Lipolytic treatment of the CAMP-binding protein. The 
outer membrane of photoaflinity labeled mitochondria was disrupted 
by limited osmotic shock (Miiller & Bandlow, 1989a). Eight aliquots 
of “shocked mitochondria” (in a volume of 300 pL each) were treated 
with CazC plus TPA, HzO, 40 units/mL phospholipase Az (PL Az) 
(20 mM MOPS/KOH, pH 8.0,5 mM MgCI2). 50 units/mL phos- 
pholipase C (PL C) (20 mM MOPS/KOH. pH 8.0.2 mM ZnCI,). 
50 units/mL phospholipase D (PL D) (20 mM KP,, pH 5.6,75 mM 
CaCI,), 25 units/mL esterase (25 mM MES/KOH, pH 6.2,30 min, 
30 “C). 1 M N H P H  (60 min, 37 “C), or 2 volumes of chlorc- 
form/methanol (2:l. pH 5.5. (10 min, 0 “C). The last sample was 
centrifuged, and the chloroform (C) and aquwus phases (A) were 
separated, dried under vacuum, and dissolved in binding buffer plus 
0.5% MEGA IO (MBller & Bandlow, 1989a). Half received 2 volumes 
of double-strength sample buffer and was analyzed directly by 
SDSPAGE (20%). With the other half (only CHCI, phase shown) 
the partitioning behavior in TX-114 was studied. All other samples 
were made 25 mM in EDTA, Half was separated into membranes 
(m) and soluble proteins (s) by two-step sucrose gradient centrifu- 
gation. The other half received I volume of 2% TX-I 14 and was 
separated into aqueous (a) and detergent phases (d). All samples 
were precipitated with 5% TCA and analyzed by SDS-PAGE (20%) 
and fluorography. 
with Ca” and phospholipids or TPA. This release is a m m -  
panied by a drastic increase in the protein’s hydrophilicity 
whereas its apparent molecular weight remains unaltered. 
Therefore, it is very unlikely that the cAMP receptor is re- 
leased by Ca”/phospholipid-dependent proteolytic removal 
of a hydrophobic transmembrane domain, through which in- 
tegral membrane proteins are most commonly anchored in 
membranes. 
Fatty acids or lipid moieties can act as membrane-anchoring 
structures of proteins. They are likely to escape detection by 
SDS-PAGE. Thus, we first studied whether any chemical 
or enzymic treatment, causing removal of fatty acids or lipids, 
mimicks the effect of Caz+ plus TPA on the release of the 
cAMP receptor from the inner membrane (Figure I). Outer 
membranes of 8-N3-[32P]cAMP photoaffinity labeled mito- 
chondria were disrupted by limited osmotic shock to gain 
access for exogenously added enzymes to the outer face of the 
inner membrane. Subsequently these ‘shocked mitochondria” 
were incubated with Ca2+ and TPA or subjected to chemical 
and enzymic lipolysis. Half of each sample was separated into 
mitoplasts and intermembrane space proteins. The other half 
was partitioned into aqueous and TX-I 14 phases. 
As expected, most of the photoaffinity labeled protein in 
untreated mitoplasts (lanes 29-32) was found associated with 
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cAMP affinity chromatography (Muller & Bandlow, 1989b). 
Each eluate was divided into halves which were incubated with 
phospholipase D or remained untreated. Both were subse- 
quently analyzed by TX-114 partitioning. Since the meta- 
bolically labeled and cAMP affinity purified protein and the 
authentic photoaffinity labeled cAMP receptor showed very 
similar elution profiles during gel filtration chromatography 
(data not shown), both proteins seemed to be identical. This 
view was strengthened by the comigration of the two radio- 
labeled “receptor preparations” during SDS-PAGE (Figure 
2, compare lane 1 with the other lanes) and by the many 
electrophoretically identical peptides, radiolabeled with 8- 
N3-cAMP or inositol, respectively, which they share after 
partial proteolysis with endoprotease V8 (data not shown). 
Figure 2 shows that the membrane-associated cAMP re- 
ceptor, recovered mainly from the detergent phase, carried 
stearic acid label as well as inositol label (lane 3). Phospho- 
lipase D action strongly diminished the stearic acid label but 
not the inositol label (lanes 4 and 5) .  which, however, was 
about equally distributed between the detergent (lane 5 )  and 
the aqueous phase (lane 4) during partitioning. Thus the 
membrane anchor of the cAMP receptor seems to consist of 
or, at least, to contain phosphatidylinositol, the glycerol being 
esterified with stearic acid. Next we examined whether the 
Ca’+/phospholipid-controlled amphitropic behavior of the 
receptor involves the cleavage of this lipid moiety. 
Stearic acid labeled as well as inositol-labeled cAMP re- 
ceptor was also observed in Ca”-treated mitochondria (lane 
7). However, a minor portion of the inositol-labeled receptor 
could now be recovered from the aqueous phase (lane 6). as 
has been found for the photoaffinity labeled receptor protein 
(Muller & Bandlow, 1989a). After treatment with Ca” plus 
TPA almost no stearic acid could be detected associated with 
the protein (lanes IO and I I). Again, incorporation of inositol 
was not affected, although the major portion of the inositol- 
labeled receptor was now found in the aqueous phase (lane 
IO). The increased proportion of water-soluble inositol-labeled 
receptor correlated well with the observed decrease in stearic 
acid labeled protein. Phospholipase D slightly increased the 
proportion of inositol-labeled protein recovered from the 
aqueous phase of Ca2+/TPA-treated mitochondria (lane 12). 
The electrophoretic analysis of phospholipase D treated cAMP 
receptor revealed that the removal of the (stearic acid con- 
taining) phosphatidyl residue did not lead to a change in the 
apparent molecular weight of the (inositol labeled) cAMP 
receptor as compared to the photoaffinity of inositol-labeled 
membrane-bound receptor (lanes I and 3). Taken together, 
the Caz+/TPA treatment and the phospholipase D action caw 
removal of stearic acid, presumably as phosphatidic acid, but 
leave the inositol moiety linked to the cAMP receptor. Upon 
lipolysis the hydrophilicity of the receptor increases. These 
data support the view that a phospholipase activity triggers 
the Ca2+/TPA-controlled amphitropic behavior of the mito- 
chondrial CAMP-binding protein. 
CalciumlPhospholipid-Controlled Release of the CAMP- 
Binding Protein Is Enzymatically Catalyzed. The deduced 
nature of the membrane anchor of the cAMP reccptor and 
its liberation into the intermembrane space by phospholipase 
D action suggested an enzymatically catalyzed releasing re- 
action under the control of Ca” and phospholipids. We tested 
for the existence of a mitochondrial releasing activity and its 
possible association with the inner membrane or residence 
within the intermembrane space, locations which both would 
permit access to the putative cleavage site within the lipid 
moiety of the receptor at  the outer face of the inner membrane. 
L 2 
FIGURE 2: Metabolic labeling of the CAMP-binding protein. Aliquols 
of mitochondria, metabolically labeled with either [’Hlinositol or 
[“C]stearic acid, were shocked, mated with or without Ca” and TPA. 
and then solubilized with 0.5% MEGA 10, and the CAMP-binding 
protein was enriched by CAMP-Sepharose affinity chromatography. 
One aliquot of each eluate was incubated with phospholipase D the 
other remained untreated. After partitioning in H,O/Triton X-114, 
the aqueous (a) and detergent (d) phases were analyzed by SDS- 
PAGE and fluorography. 8-N3-[”P]cAMP affinity labeled CAMP- 
binding protein was run in a parallel lane on the same gel (ma). 
the membrane fraction (lane 32) and recovered from the de- 
tergent phase after partitioning (lane 30). Similarly, acidic 
chloroform/methanol extraction of the membranes (lanes 5-8) 
which solubilized a significant portion of the receptor (lane 
7) did not increase the portion of CAMP-binding protein in 
the aqueous phase (lane 5 ) .  Thus the lipophilic membrane 
anchor appears to be covalently attached to the protein moiety 
of the receptor. This contrasts to the Ca”/TPA-controlled 
release of the receptor (lanes 1-4): most of the protein was 
found in the soluble fraction after this treatment (lane 3). 
Consequently, the recovery from the aqueous phase after 
partitioning (lane 1) argued that the released version was 
hydrophilic and thus had lost the membrane anchor during 
the Ca2+/TPA treatment. We then assayed whether also 
hydroxylamine, esterase, or various phospholipases are able 
to release the protein from the membrane with concomitant 
decrease of its lipophilicity. Alkaline hydroxylamine was 
inefficient (lanes 9-12), suggesting that the CAMP-binding 
protein is not acylated with fatty acids via thioester bonds. 
Oxyester linkage was excluded by an experiment where mi- 
toplasu were treated with esterase (lanes 13-16). The receptor 
was retained in the mitoplast fraction (lane 16) or in the 
detergent phase, respectively (lane 14). However, phospho- 
lipase D (lanes 17-20), but not phospholipases A, and C (lanes 
21-28), solubilized about SO% of the membrane-bound re- 
ceptor protein (lane 19) with a concomitant increase in hy- 
drophilicity to about the same degree (lane 17). This is a first 
indication of a covalently bound lipid structure that functions 
as a membrane anchor for the cAMP receptor. 
CAMP-Binding Protein Carries a Phosphatidylinositol 
Anchor, Which Is Removed by Phospholipase D and Ca2+/ 
TPA Treatment. The release of the cAMP receptor protein 
from the inner mitochondrial membrane by phospholipase D 
would predict that the membrane-embedded form of the re- 
ceptor contains phosphatidic acid which is absent from the 
soluble version. On the other hand, both forms should contain 
the specific alcohol head group linked to the protein moiety. 
A metabolic labeling experiment shows that this is, in fact, 
the case (Figure 2). 
Yeast cells were grown in the presence of radiolabeled 
stearic acid or inositol. Isolated mitochondria were treated 
with or without Ca” and TPA, solubilized, and subjected to 
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FIGURE 3: (A) Effect of the intermembrane space on the release of 
the cAMP receptor. Mitochondria were separated into mitoplasts 
and intermembrane space. The intermembrane space fraction was 
precipitated (30% PEG 4000, 15 min, 0 "C/5 min, microfuge) and 
dissolved (10 mg/mL in binding buffer). Purified mitoplasts received 
either 120 pg of intermembrane space fraction (+IMS) or received 
buffer (-IMS). Aliquots of both samples were incubated in the 
presence or absence of CaZ+ and TPA and subsequently separated 
into mitoplasts and soluble proteins by two-step sucrose gradient 
centrifugation. The soluble proteins were precipitated by 30% PEG 
4000, dissolved, and desalted by passage through a 0.5-mL column 
of Sephadex G-25. All samples were tested for CAMP-binding activity. 
The released CAMP-binding activity, measured in the supernatant, 
is given as the percentage of total cAMP binding of mitoplasts and 
soluble proteins. 100% cAMP binding is 0.25 pmol of cAMP/mg 
of protein in this experiment. (B) Kinetics of the release of the 
CAMP-binding protein. Aliquots of mitoplasts (250 pg) were incubated 
each with 5 ,  10,20,50, 100, or 200 pg of intermembrane space protein 
(see legend to Figure 4) in the presence of Ca2+ plus TPA. After 
2-, 5- ,  IO-, 15-, 20-, 25-, 30-, and 40-min incubation at 25 "C aliquots 
of the mixtures were removed, supplemented with EGTA, cooled to 
0 "C, and separated into mitoplasts and soluble proteins by two-step 
sucrose gradient centrifugation. All samples were further processed 
and assayed for CAMP-binding activity as described for (A). 100% 
CAMP-binding is 0.3 1 pmol of cAMP/mg of protein in this experiment. 
For this purpose, photoaffinity labeled mitoplasts were treated 
with Ca2+ and TPA in the presence or absence of soluble 
proteins of the intermembrane space. Figure 3A shows that 
the release of the CAMP-binding protein, effected by Ca2+ 
alone, did not depend on the presence of intermembrane space 
proteins. By contrast, the efficient Ca2+/TPA-controlled 
solubilization strictly required the presence of a fraction of 
the intermembrane space. In its absence only the TPA-in- 
dependent release occurred. 
To corroborate the enzymic nature of the releasing activity 
and its location in the soluble intermembrane space, we ex- 
amined whether the efficiency of the intermembrane space 
fraction dependent releasing reaction depends on time and 
amount of this fraction present during the incubation. Purified 
mitoplasts were supplemented with increasing concentrations 
of intermembrane space fraction and incubated for variable 
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FIGURE 4: Protein nature of the releasing factor. Aliquots of mitoplasts 
(200 pg each) were supplemented with 40 pg of intermembrane space 
fraction which had been preincubated with heat ( 5  min, 95 "C), 10 
pg/mL RNase A (15 min, 20 "C), 50 pg/mL trypsin (TRY) in the 
absence or presence of a 4-fold molar excess of soy bean trypsin 
inhibitor plus 200 pM PMSF (INH) (60 min, 0 "C), on 1 mM 
N-ethylmaleimide (NEM) in the absence or presence of 2 mM DTT 
(15 min, 0 "C) or had remained untreated. The trypsin or NEM 
treatment of intermembrane space proteins was stopped prior to their 
addition to mitoplasts by incubation with trypsin inhibitor plus PMSF 
or DTT, respectively (see above). One aliquot was supplemented with 
40 pg of intermembrane space protein which had been passed through 
a 1-mL column of Sephadex G-10 (GELF.). Subsequently, all samples 
were incubated with Ca2+ plus TPA, separated into mitoplasts 
(membrane bound) and soluble proteins (released) by two-step sucrose 
gradient centrifugation, and analyzed for released CAMP-binding 
activity. 100% of total CAMP-binding refers to 0.35 pmol of 
cAMP/mg of protein in the unfractionated incubation mixture. 
periods of time. The mixtures were subsequently separated 
into mitoplasts and soluble proteins. Both fractions were 
assayed for CAMP-binding activity. Figure 3B reveals that, 
with up to 50 pg of intermembrane space fraction per 250 pg 
of mitoplasts, the velocity of the releasing reaction (7 min for 
half-maximal release) was linear with time (up to 10 min) and 
yielded maximum release (up to 42% of the initial CAMP- 
binding activity); 100 pg of intermembrane space fraction 
caused a further increase of the reaction velocity but strongly 
reduced linearity with time and maximum release. Still higher 
amounts inhibited the release of the cAMP receptor. Incu- 
bation times longer than 20 min diminished the CAMP-binding 
activity. This agrees well with the observed loss of activity 
due to the rapid proteolytic turnover of the protein after 
Ca2+/TPA treatment of whole mitochondria (Muller & 
Bandlow, 1989a). The portion of released receptor observed 
both in the reconstituted system and in the assay using whole 
mitochondria was comparable. Since the intermembrane space 
contributes only about 10% to the total mitochondrial protein, 
either the amount of active releasing factor is limiting in 
mitochondria, or our reconstituted assay works less efficiently 
than whole mitochondria. Taken together, the time course 
and dependence on the amount of intermembrane space 
fraction strongly argue for an enzymic (releasing) activity in 
that compartment which mediates the Ca2+/phospholipid- 
controlled conversion of the membrane-bound form into the 
soluble form of the receptor. 
Calcium/Phospholipid-Controlled Release of the CAMP- 
Binding Protein Requires a Protein of the Intermembrane 
Space. We attempted to characterize the nature of the re- 
leasing activity in the intermembrane space. Figure 4 dem- 
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onstrates its proteinaceous character. Mitoplasts were incu- 
bated with constant amounts of intermembrane space fraction 
(50 gg). Pretreatment of intermembrane space proteins with 
heat, trypsin, and N E M  completely inhibited release of the 
receptor from the membrane. By contrast, trypsin in the 
presene of inhibitor, NEM quenched with DTT, RNase, or 
gel filtration, which would remove low molecular weight 
components, had almost no effect. Thus a t  least one soluble 
IVEM-sensitive protein of the intermembrane space, termed 
releasing factor, participates in the releasing process by ul- 
timately causing-either in a direct or regulatory fashion- 
cleavage of the lipid anchor of the cAMP receptor. 
DISCUSSION 
The cAh4P-binding protein in mitochondria of the yeast 
Saccharomyces cerevisiae represents the first case of an in- 
tracellular protein which is bound to a biological membrane 
via a covalently attached lipid moiety. It can be metabolically 
labeled with inositol and stearic acid. The fatty acid label but 
not the inositol label is removed by phospholipase D action. 
These features are characteristic for an inositol-containing 
phospholipid esterified with stearic acid. Up to now, this type 
of membrane anchor has been described only for several eu- 
caryotic extracellularly exposed plasma membrane proteins 
[for review, see Low (1987)l. 
It is unclear why only stearic acid is efficiently incorporated 
into the cAMP receptor protein in contrast to palmitic acid 
(data not shown), since the latter one is 4-fold more abundant 
in yeast mitochondria (Paltauf & Schatz, 1969). Fatty acids 
may differ in their uptake rates into yeast mitochondria or 
intracellular pools (Daum, 1985). The mitochondrial cAMP 
receptor appears to be linked exclusively to phosphatidylinositol 
since radiolabeled ethanolamineZ and choline could not be 
detected in this protein after metabolic labeling (data not 
showii). Phosphatidylinositol accounts only for about 8% of 
total phospholipids in the yeast inner mitochondrial membrane 
(Bottema & Parks, 1980). 
The chemical nature of the linkage between the inositol 
nioiety and the protein remains to be elucidated. In eucaryotic 
plasma membrane proteins having a lipid membrane anchor, 
the phosphatidylinositol is coupled via a complex glycan 
structure through an ethanolamine bridge to the carboxy 
terminus of the protein (Rose et al., 1984; Ferguson et al., 
1988). Alternatively, the alcoholic head group of phospha- 
tidylinositol may be linked via a phosphodiester bridge to 
internal hydroxylated amino acids of the protein. This type 
of linkage would be more compatible with the mitochondrial 
location of the cAMP receptor since glycosylation seems to 
be restricted to lipids and proteins moving along the secretory 
pathway (Palade, 1975). The absence of glycosyl residues 
might also explain the inability of the bacterial toxin phos- 
phoinositol glycan specific phospholipase C to cleave the re- 
ceptor into diacylglycerol and the phosphoryl-inositol-protein 
moiety (Bangs et al., 1986). 
Phospholipase D effects membrane release of the cAMP 
receptor. Concomitantly, the protein’s hydrophilicity increases. 
Thus the anchoring of the cAMP receptor in the inner mito- 
chondrial membrane appears to be accomplished solely by the 
inositol phospholipid. The existence of this type of mito- 
chondrial membrane protein raises some intriguing questions 
about its biosynthesis. In  higher eucaryotes, glycophospho- 
lipid-anchored plasma membrane proteins are synthesized as 
precursors with a short stretch of hydrophobic amino acids 
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at the C-terminus (Boothroyd et al., 1980; Cross, 1984; Seki 
et al., 1985; Oikawa et al., 1987; Berger et al., 1988) which 
does not appear in the mature phosphatidylinositol glycan 
tailed product. This domain is believed to transiently span 
the membrane of the endoplasmic reticulum as the protein 
starts its way along the secretory pathway to the cell surface 
(Takami et al., 1988b) and to be ultimately replaced by the 
prefabricated core glycolipid anchor (Menon et al., 1988) in 
a pseudotranspeptidation reaction (Bangs et al., 1985; Krakow 
et al., 1986). The amino acid sequence deduced from the gene 
for the mitochondrial cAMP receptor will reveal whether it 
exhibits similar sequence prerequisites and mechanisms for 
phospholipid attachment as plasma membrane proteins (Caras 
et al., 1987, 1989). Interestingly, extracellular lipoproteins 
of Gram-positive bacteria which exhibit homology to soluble 
periplasmic sugar- and oligopeptide-binding proteins in 
Gram-negative bacteria (Dudler et al., 1988; Gilson et al., 
1988) become attached to the plasma membrane via a gly- 
ceride moiety linked to the N-terminal cysteine of the mature 
protein after transient membrane anchoring by the signal 
peptide. I t  was also suggested that this “lipoprotein modifi- 
cation offers the Gram-positive bacterium an efficient way of 
retaining a variable portion of its secreted proteins in an active 
releasable form” (Nielsen & Lampen, 1982). 
The degradation of phospholipid-modified proteins requires 
phospholipases. Such enzymes are present in all cellular 
membranes. Caz+-independent phospholipase A, from rat 
heart mitochondria is associated with the outer face of the 
outer membrane (Palmer et al., 1981), whereas Ca2+-de- 
pendent phospholipase Az is located within the matrix/in- 
termembrane space (Cheah & Cheah, 1981). Here we de- 
scribe an enzymic activity in yeast mitochondria which exhibits 
phospholipase action. The data, obtained from metabolic 
labeling experiments, are compatible with phospholipase A, 
C, or D action. The mitochondrial phospholipase activity is 
observed only in the presence of Ca2+, phospholipid (or lipid 
derivatives), and NEM-sensitive protein(s) of the intermem- 
brane space (releasing factor). This suggests a location of the 
enzyme itself and/or regulatory components in that com- 
partment. From the experiments presented so far it remains 
open whether CaZ+, phospholipids, and the releasing factor(s) 
participate altogether in the lipolytic cleavage reaction or affect 
mechanistically different steps of the releasing process. In an 
accompanying paper we succeeded in separating a Ca2+-de- 
pendent posttranslational modification of the CAMP-binding 
protein from the phosholipid-dependent activation of the 
mitochondrial phospholipase (Muller & Bandlow, 1989b). 
The described lipolytic activity is, most likely, not or not 
only involved in the degradation of the mitochondrial cAMP 
receptor but probably plays an important role in controlling 
its intramitochondrial location. The soluble CAMP-binding 
protein, released into the intermembrane space by the mito- 
chondrial phospholipase, may regulate certain mitochondrial 
functions by converting a CAMP-dependent protein kinase to 
its activatable form (Muller & Bandlow, 1987, 1989a). 
Analogously, extracellular phospholipases are believed to re- 
lease mammalian phosphatidylinositol-anchored plasma 
membrane proteins from the cell surface into the blood stream 
where they exert their biological function (Fox et al., 1986; 
Hereld et al., 1986; Davitz et al., 1987). Thus, phospholipases 
may elicit physiological responses not only through the hy- 
drolysis products of phospholipids but also by the (irreversible) 
liberation of phospholipid-modified proteins from biological 
membranes. 
* Ethanolamine labeling of the cAMP receptor protein was, however, 
observed wi th  CHO cells (G. Muller, unpublished results). Registry No. Phospholipase, 901 3-93-8. 
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